17/05/2021 – 10:50
The Ministry of Health has promised to decide this week what to do with the second dose of AstraZeneca. However, Dr. César Carballo has stated that the intention of the health authorities is to inject Pfizer as a second dose of AstraZeneca.
“The decision has already been made (…) Pfizer is going to play, for sure. Despite what the studies say.” This is how forceful the urgeniologist César Carballo was in one of his interventions in the program the Sixth Night last saturday. In the doctor’s opinion, the Ministry of Health has extended the interval between doses to 16 weeks to obtain the results of a clinical trial despite the fact that the pharmaceutical company leaflet says 12.
Health values giving AstraZeneca in people over 40 and Pfizer in minors
Precisely, the only decision that Spain has made has been to delay the space between doses of AstraZeneca from 12 to 16 weeks. A measure that was taken to buy time to know the results of Combivacs, a clinical trial that is being carried out at the Carlos III Institute in Madrid and is investigating the suitability of combining the Oxford serum with Pfizer.
Preliminary results of this study will be released this week. Thus, the Interterritorial Council of the National Health System is expected to make a decision this Wednesday, but the possibilities are three:
1. Inject Pfizer as a second dose: This is the position that the Ministry of Health is expected to propose, since the objective of the clinical trial that is awaiting is to clarify whether the people who have received the first dose of AstraZeneca have generated enough antibodies or a booster dose with another vaccine is required.
2. Inject AstraZeneca voluntarily: this position is the one defended by some autonomous communities. However, the Ministry of Health totally rejected voluntary vaccination with AstraZeneca for those under 60 years of age.
3. Administer AstraZeneca in the 40-60 age group: This is the position put on the table by the Vaccine Report, made up of health experts from the Ministry, during the Public Health Commission last week. In addition, it is the decision that the United Kingdom health authorities made last Friday, which raised the limit of AstraZeneca from 30 to 40 years.